Vaira LA, Hopkins C, Salzano G, et al. - In this investigation, researchers reported and analyzed the outcomes of a large Italian multicenter study that objectively examined chemoreceptive disorders in COVID‐19 patients. Four Italian hospitals conducted the multicenter study: Sassari University Hospital, Salerno University Hospital, San Paolo Hospital in Milan, Bellaria‐Maggiore Hospital in Bologna. For this analysis, 345 COVID‐19 patients [mean age 48.5 ± 12.8 (range 23‐88)] underwent objective chemosensitive evaluation. There were no important differences between the presence and severity of chemosensitive disorders and the severity of the clinical course. The incidence of chemosensitive disorders is less stated by patients. Contrarily to recent reports, such objective testing refutes the proposal that the presence of olfactory and gustatory dysfunction may anticipate a milder course, but instead indicates that those with more severe illness neglect such symptoms in the setting of severe respiratory disease.